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The B cell receptor (BCR) displays the dual 
function of sensing tonic signals for B cell sur-
vival at rest and of triggering B cell activation 
and differentiation into antibody-producing 
cells upon ligation with the appropriate anti-
gen. The valency requirements for each of these 
functions remain incompletely understood. To 
achieve full B cell activation, the prevailing 
view holds that the BCR remains monomeric in 
resting B cells and clusters upon cross-linking 
only by a multivalent antigen (Woodruff et al., 
1967).  High-resolution  live  cell  imaging  has 
clarified our view of the BCR distribution in 
resting  and  activated  B  cells. Total  internal   
reflection  fluorescence  microscopy  suggests 
that most BCRs are apparently monomeric on 
the cell surface and diffuse freely, with a lesser   
percentage comprised of dimers and immobile 
oligomers; BCR engagement leads to BCR clus-
tering (Tolar et al., 2005). Studies on the BCR 
complex reconstituted in insect cells provide an 
alternative view and indicate that BCRs are pres-
ent as autoinhibited oligomeric complexes at 
rest; ligand binding then improves accessibility 
of immunoreceptor tyrosine-based activation 
motifs (ITAMs) and “opening” of these oligo-
mers, culminating in B cell activation (Yang 
and Reth, 2010). Consistent with this theory, 
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Valency requirements for B cell activation upon antigen encounter are poorly understood. 
OB1 transnuclear B cells express an IgG1 B cell receptor (BCR) specific for ovalbumin 
(OVA), the epitope of which can be mimicked using short synthetic peptides to allow antigen-
specific engagement of the BCR. By altering length and valency of epitope-bearing  
synthetic peptides, we examined the properties of ligands required for optimal OB1 B cell 
activation. Monovalent engagement of the BCR with an epitope-bearing 17-mer synthetic 
peptide readily activated OB1 B cells. Dimers of the minimal peptide epitope oriented in an 
N to N configuration were more stimulatory than their C to C counterparts. Although 
shorter length correlated with less activation, a monomeric 8-mer peptide epitope behaved 
as a weak agonist that blocked responses to cell-bound peptide antigen, a blockade which 
could not be reversed by CD40 ligation. The 8-mer not only delivered a suboptimal signal, 
which blocked subsequent responses to OVA, anti-IgG, and anti-kappa, but also competed 
for binding with OVA. Our results show that fine-tuning of BCR-ligand recognition can 
lead to B cell nonresponsiveness, activation, or inhibition.
© 2014 Avalos et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Figure 1.  OVA-specific OB1 B cells are activated by peptide containing the epitope FGD. (A) OB1 B cells were incubated on ice in the absence (con-
trol) or presence of biotinylated versions of 0.5 µM FGD 17-mer and AGA 17-mer peptides. Binding was detected by flow cytometry using SA-APC. (B) OB1  
B cells were stimulated with equimolar (0.5 µM) FGD 17-mer, AGA 17-mer, or OVA or 5 µg/ml anti-IgG1 or anti-IgM for 3 min, and then lysates were run in 
SDS-PAGE and immunoblotted with anti–phospho-ERK (top) or anti–total ERK (bottom). (C) OB1 B cells were loaded with Ca2+-sensitive Indo-1 AM dye and 
collected for 1 min (unstimulated baseline). After that, 5 µM FGD 17-mer, AGA 17-mer, or OVA or 5 µg/ml anti-IgG1 was added and collected for five addi-
tional minutes. (D) OB1 B cells were resuspended in serum-free or serum-complete RPMI, and Ca2+ trace was collected as in C upon incubation with 0.5 µM 
FGD 17-mer. (E) OB1 B cells loaded with Indo-1 AM dye were preincubated with 50 nM Btk inhibitor for 30 min at 37°C, and Ca2+ trace was collected upon 
stimulation with 0.5 µM FGD 17-mer. (F) Render of z-stacks of confocal microscopy of OB1 MHC II GFP B cells that were incubated for 10 min with Alexa 
Fluor 647–labeled FGD or AGA 17-mer or FluB1 MHC II B cells stimulated with Alexa Fluor 647–labeled FGD 17-mer. (G) OB1 B cells were either left unstimu-
lated or stimulated with 17-mer or anti-IgG for 15 min in the presence of 100 µM dynasore at 37°C and stained with anti–mouse IgG antibody conjugated 
with Alexa Fluor 405 and Alexa Fluor 647 for STORM imaging. Representative fields (left) and single-cell images from selected box regions (right) are shown. 
Bars: (F) 2 µm; (G, left) 5 µm; (G, right) 1 µm. (H) The percentage of clusters that have more than three BCRs (top), the cluster size (middle), and the number of JEM Vol. 211, No. 2 
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more  favorable  when  compared  with  C-C.  Reduction  of 
peptide length is accompanied by a decrease in B cell activa-
tion. A suboptimal 8-mer peptide species prevents further re-
sponses  to  cell-bound  antigen.  Our  data  are  also  the  first   
report of an antigen-specific response of primary B cells car-
rying a complete IgG1 BCR.
RESULTS
OVA-specific B cells are activated by OB1 peptide 
containing the epitope FGD
The binding of OB1 serum to a series of peptides that span 
the OVA sequence allowed identification of the epitope rec-
ognized by the OB1 BCR, centered on the peptide DKLPG-
FGDSI, where the FGD sequence is essential (Dougan et al., 
2012). To further explore the requirement of this sequence for 
binding of OVA to the BCR, we generated a 17-residue bio-
tinylated peptide that contains the core FGD sequence, FD-
KLPGFGDSIEAQGGK (FGD 17-mer) and tested binding 
to OB1 B cells from OB1 mice. We compared its binding 
with that of a 17-mer in which AGA replaced the FGD seg-
ment, FDKLPGAGASIEAQGGK (AGA 17-mer). OB1 B cells 
bound the FGD 17-mer but not the AGA 17-mer (Fig. 1 A). 
The FGD 17-mer but not the AGA 17-mer elicited robust 
phosphorylation of the MAP kinase ERK1/2, a downstream 
effector of BCR engagement (Fig. 1 B; Kurosaki et al., 2010). 
Accordingly, the FGD 17-mer but not the AGA 17-mer elic-
ited a calcium (Ca2+) flux (Kurosaki et al., 2010) comparable 
with that elicited by OVA (Fig. 1 C). The 17-mer peptide is 
water-soluble and shows no signs of aggregation. Given its 
size and hydrophilicity, we considered oligomerization of   
the FGD 17-mer unlikely. Still, we tested whether inclusion 
of serum could lead to peptide aggregation. B cells stimulated 
with FGD 17-mer in serum-free medium responded com-
parably with those cultured in serum-containing medium 
(Fig. 1 D). Ca2+ flux evoked by the FGD 17-mer was blocked 
by an inhibitor of Bruton’s tyrosine kinase (Btk), required for 
the initial steps of BCR signaling (Fig. 1 E; Mohamed et al.,   
2009). To determine the path followed by FGD 17-mer upon 
binding to the BCR, we prepared Alexa Fluor 647–conjugated 
versions of FGD and AGA 17-mer and added them to OB1-
MHC class II GFP B cells for 10 min. We removed unbound 
material by washing and determined the extent of antigen 
internalization by confocal microscopy. FGD 17-mer was   
internalized and localized to MHC II GFP+ compartments;   
as expected, we did not detect any AGA 17-mer inside cells 
(Fig. 1 F), arguing against pinocytosis as the means of peptide 
acquisition. To further ensure that peptide internalization re-
quired the BCR and was not attributable to pinocytosis, we 
incubated FGD 17-mer with FluB1 MHC II GFP transnuclear 
stochastic optical reconstruction microscopy (STORM) al-
lowed identification of IgM and IgD clusters on resting B cells 
(Mattila et al., 2013). Diffusion of the BCR and signaling de-
pend  on  the  actin  cytoskeleton;  the  actin-depolymerizing 
agents latrunculin A and cytochalasin D promoted BCR acti-
vation and diffusion even in the absence of antigen (Treanor   
et al., 2010). Thus, at rest, BCR diffusion is restricted, whereas 
upon antigen binding the BCR diffuses more rapidly, likely 
disaggregates, and disperses to help capture more antigen (Fleire 
et al., 2006). BCRs may then form caps, which lead to internal-
ization  and,  ultimately,  presentation  of  captured  antigen  on 
MHC class II molecules. Antigens that favor such BCR move-
ment may indeed be best at attaining full B cell activation.
The aforementioned studies evaluated BCR dynamics 
but did not address the valency of the BCR-stimulating ligand. 
Indeed, the valency requirements for efficient BCR activa-
tion continue to be an underexplored aspect of B cell biology. 
Polyclonal activation of B cells is usually achieved using the 
F(ab)2 portion of anti–mouse IgM, which targets constant 
regions of BCR rather than its antigen-binding site. Existing 
transgenic mice are directed to protein antigens such as hen 
egg lysozyme (HEL; Goodnow et al., 1988), DNA (Erikson 
et al., 1991), or hapten (Shih et al., 2002). Existing transgenic 
BCR models are ill-suited for valency studies because of the 
tendency of proteins to form aggregates in serum-containing 
medium and thus yield ligands of unknown valency. The re-
petitive nature of DNA and the requirement for a carrier 
protein or other polymer in the case of hapten-specific BCR 
complicate the use of correspondingly specific transgenic 
BCR models to address valency. Still, using anti-HEL BCR 
transgenic mice, monomeric HEL triggered BCR responses 
but was inefficient at inducing antigen presentation (Kim et al., 
2006). Varying the number of 3-nitro-4-hydroxy-5-iodo-
phenylacetate (NIP) hapten molecules in peptides demon-
strated that low valency antigen could still activate B cell 
responses (Minguet et al., 2010). Thus, cross-linking of the 
BCR by multivalent antigen may not be strictly required to 
activate B cells.
To explore BCR activation of an antigen-specific B cell 
population, we generated mice by somatic cell nuclear trans-
fer, using the nucleus of an OVA-specific B cell as donor. The 
resulting OB1 mice produce an OVA-specific IgG1 that   
recognizes OVA in both native and denatured forms. Short 
synthetic peptides mimic the epitope recognized by OB1 
(Dougan et al., 2012). By controlling the size of the peptide 
epitope and its display as a monovalent, bivalent, or cell sur-
face entity, we here examine the activation requirements of 
the IgG1 OB1 BCR. Monovalent engagement of this BCR 
suffices to activate OB1 B cells. Dimerization further enhances 
activation, with N-N orientation of the epitope being somewhat 
localizations within clusters (bottom) between unstimulated, 17-mer, and anti-IgG conditions were quantified, and means and SDs are plotted. Unpaired 
Student’s t test was performed comparing the total number of clusters contained in unstimulated versus the 17-mer or the anti-IgG condition. The number 
of cells analyzed was 67 (unstimulated), 102 (17-mer), and 118 (anti-IgG). P values of resulting analysis are shown: *, P = 0.024; ***, P = 0.0004; ****, P < 
0.0001. Results shown are representative of two (A, G, and H) and at least three independent experiments (B–F).
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supernatant. To compare binding of nested peptides to that of 
OVA, we constructed a competitive ELISA assay using plate-
bound OVA and added a nonsaturating amount of OB1 anti-
body, together with a range of concentrations of OVA and 
peptides as competitors. OVA and the longer peptides com-
peted efficiently for binding of OB1 to the OVA coat, but as 
the peptide was shortened, its ability to compete for binding 
was hindered (Fig. 2 D, left). We prepared Fab fragments from 
OB1 antibody by digestion with immobilized papain. All 
FGD-containing peptides competed for binding, with only 
the 4-mer peptide somewhat less efficient at doing so (Fig. 2 D, 
right). Thus, the residues flanking the FGD sequence appear 
more important for binding to the whole antibody and less so 
for binding to Fab.
We next explored the possible contribution of the resi-
dues flanking the FGD sequence to binding and activation. 
We generated peptides that retained the FGD core sequence 
but either with the adjacent residues altered to amino acids of 
similar polarity (17-mer substituted) or exchanged for alanine 
for all but four residues (17-mer hydrophobic). We also made 
single amino acid replacements in the FGD motif (17-mer 
FGA and AGD mutants; Fig. 2 A). None of these peptides 
bound to the OB1 Fab fragment (Fig. 2 E) nor did they acti-
vate B cells (not depicted). Thus, optimal binding and activa-
tion of OB1 B cells by 17-mer requires the presence of both 
the FGD core and its adjacent residues.
Peptide dimerization and N-N orientation favor  
enhanced B cell stimulation
To bring BCR molecules in close proximity, the epitope in 
dimeric versions of antigen may interact with BCR in a pre-
ferred orientation (head to head, tail to tail, or head to tail). 
To define which epitope orientation best favors BCR acti-
vation, we created dimeric ligands of defined topology by 
synthetizing peptides connected in head to head (N-N) or 
tail to tail (C-C) fashion (Fig. 3, A and B, top) by means of 
a click reaction. The two peptides remain separated by a 
flexible linker, which in fully extended form is calculated to 
span a distance of 3 nm (30 Å). Regardless of the FGD 
orientation in these dimers, their stimulatory capacity as re-
corded by Ca2+ flux was comparable with, if not higher, 
than that recorded for 17-mer peptide alone at a concentra-
tion of 0.01 µM (Fig. 3 A, middle). When the concentration 
of 17-mer was brought down to suboptimal levels (0.001 µM), 
we could see the enhancement in stimulation by 17-mer   
dimerization with no apparent difference between the N-N 
and C-C orientation (Fig. 3 A, bottom). Because the FGD 
17-mer peptide was already strongly stimulatory, we instead 
focused our attention on the FGD 8-mer peptide to more 
rigorously test the most favorable epitope orientation required 
for stimulation. The FGD 8-mer at 0.5 µM as monomer was 
poor in its ability to stimulate ERK1/2 phosphorylation and 
Ca2+ flux (Fig. 2, B and C). We generated N-N and C-C di-
mers for the FGD 8-mer peptides, which induced responses 
at a concentration of 0.5 µM, at which FGD 8-mer monomer 
B cells, which are specific for hemagglutinin (HA; Dougan 
et al., 2013) and thus should not internalize FGD 17-mer, 
unrelated in sequence to flu HA. The FGD 17-mer did not 
accumulate in FluB1 cells (Fig. 1 F), thus confirming the re-
quirement of BCR specificity for internalization.
Only multivalent antigens can cross-link the BCR mol-
ecules. Aggregation of the BCR subsequent to initial en-
gagement  may  require  the  involvement  of  cytoskeletal 
elements, but not necessarily cross-linking of the BCR by 
exposure to monovalent antigen. Based on its size, amino 
acid composition, and behavior as a monomer in solution, 
we did not expect the 17-mer to elicit BCR cross-linking in 
the manner of a multivalent ligand. To determine whether 
17-mer  could  promote  BCR  aggregation,  we  performed 
STORM experiments, with a lateral resolution of 20–30 nm 
(Rust et al., 2006; Huang et al., 2010) to directly examine 
the distribution of the BCR. To ensure that the BCR would 
remain confined to the cell surface, we incubated OB1 B cells 
with dynasore to prevent BCR internalization, a rapid pro-
cess (Chaturvedi et al., 2011). OB1 B cells were either left 
unstimulated or treated with 17-mer or anti-IgG (positive 
control to evoke BCR aggregation) in the presence of dyna-
sore for 15 min, fixed, and stained with Alexa Fluor 405–   
and Alexa Fluor 647–conjugated anti–mouse IgG to visualize 
the  BCR  and  imaged  by  STORM. Anti-IgG  treatment 
readily evoked a strong aggregation of BCR at the cell sur-
face (Fig. 1 G), as reflected by a significant increase of the 
percentage of clusters with more than three BCRs (as de-
fined by more than three antibody localizations used to de-
tect the BCR), a larger cluster size, and with higher number 
of localizations per cluster (Fig. 1 H). The 17-mer promoted 
BCR clustering to a level comparable with that elicited by 
anti-IgG (Fig. 1, G and H). The low initial percentage of 
clusters with more than three BCRs (5%) suggests that in 
OB1 B cells most surface BCR behaves as a monomer. Thus, 
a monomeric 17-mer peptide can signal and trigger cluster-
ing of the BCR.
Shorter peptides containing the FGD sequence bind  
to OB1 B cells but fail to elicit a response
To determine the extent to which a response required the 
FGD-flanking residues, we synthesized a nested set of pep-
tides centered on the FGD sequence, from the benchmark 
17-mer down to a 4-residue peptide (Fig. 2 A). We then re-
corded phosphorylation of ERK1/2. Shorter peptides caused 
delayed ERK1/2 phosphorylation, the 4-mer being inactive 
(Fig. 2 B). As expected, the AGA 17-mer did not stimulate 
ERK1/2 phosphorylation. We observed a similar correlation 
between peptide length and the ability to elicit a Ca2+ flux 
(Fig. 2 C). Thus, amino acids flanking the FGD motif must be 
present to efficiently trigger a response.
To examine whether the diminishing responses to pro-
gressively shorter peptides were caused by deficiencies in 
binding to OB1 IgG1, we used OB1 B cells to generate hy-
bridomas and purified the OB1 antibody from hybridoma JEM Vol. 211, No. 2 
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Suboptimal stimulation of BCR leads to suppression  
of response to antigen
The OB1 antibody and Fab fragment bound the FGD 8-mer 
(8-mer from now on) and FGD 17-mer (17-mer from now 
on) peptide equally well, yet the 8-mer triggered a subopti-
mal Ca2+ response and failed to elicit optimal ERK phos-
phorylation (Fig. 2). To explore the consequences of this 
mode of signaling, we asked whether preincubation with   
8-mer would affect subsequent responses to 17-mer. Upon   
incubation with 0.5 µM 8-mer, OB1 B cells generated a   
sustained low-grade Ca2+ flux that prevented a subsequent 
Ca2+  spike  in  response  to  equimolar  concentrations  of   
17-mer (Fig. 4 A). The 8-mer interfered with stimulation by 
OVA at equimolar concentrations and also in response to 
anti-IgG and anti-kappa stimulation, albeit to a lesser extent 
was unable to do so (Fig. 3 B, bottom). Dimerization thus 
improves BCR responses, and the N-N orientation appears 
more favorable when compared with the C-C orientation 
for the FGD 8-mer. We next synthesized progressively lon-
ger peptides containing two, three, four, or six repeats of   
the FGD 8-mer in N-C configuration. As the number of 
epitopes increased, so did the ability to flux Ca2+ at a faster 
rate and to higher levels (Fig. 3 C). Thus, increasing the 
number of epitopes correlates with better responses, and this 
must be caused by enhancement of BCR cross-linking. Our 
results also show a subpopulation of stronger responders that 
becomes more prominent as the number of epitopes in-
creases. This population was enriched in marginal zone B cells 
(not depicted), but the identity of these cells remains to   
be elucidated.
Figure 2.  Shorter peptides containing the FGD sequence bind to OB1 B cells but fail to elicit a response. (A) Sequence of peptides nested on 
the FGD epitope bearing 17, 12, 8, and 4 amino acids, the mutant (mut) AGA 17-mer, and 17-mer peptides where the flanking residues were either substi-
tuted by same-polarity amino acids (17-mer subs), by hydrophobic amino acids with the exception of four serines (17-mer hydroph), or 17-mer peptides 
in which the core FGD was mutated to AGD or FGA. (B) OB1 B cells were stimulated with 0.5 µM of each FGD 17-mer, OVA, 12-, 8-, and 4-mer peptides 
for 1 and 3 min, and AGA 17-mer (mut) for 3 min, and then lysates were run in SDS-PAGE and immunoblotted with anti–phospho-ERK (top) or anti–total 
ERK (bottom). (C) OB1 B cells were loaded with Indo-1 AM, stimulated with 0.5 µM FGD 17-, 12-, 8-, and 4-mer and 17-mer AGA (mut), and Ca2+ flux 
traces were collected. (D) ELISA plates were coated with 0.1 µM OVA, and then 50 ng/ml of whole OB1 antibody (left) or 500 ng/ml OB1 antibody Fab 
(right) plus increasing concentrations of FGD 17-, 12-, 8-, and 4-mer, AGA 17-mer mutant peptide, or OVA were added. Plates were developed with anti-
IgG1 HRP (left) or anti-Fab HRP (right). (E) Competitive ELISA was performed as in D but adding increasing concentrations of 17-mer subs, hydroph, AGD,  
or FGA, according to the sequences in A. Results are representative of three (B and C) independent experiments. In D and E, mean + SEM of two (whole 
antibody) and three (Fab) independent experiments is shown.370 Monovalent engagement of the BCR | Avalos et al.
FGD 17-mer (not depicted). Thus, when the BCR is stimu-
lated suboptimally, it cannot then be efficiently triggered by 
optimal ligand.
Computational modeling reveals different behavior  
of 17-mer, 8-mer, and OVA despite comparable Kd
Our ELISA results showed that the 8-mer and 17-mer com-
peted equally for OVA binding to the OB1 antibody, yet the 
8-mer blocked responses to equimolar 17-mer, while being 
incapable of inducing a robust Ca2+ response when added   
on its own. These observations stressed the need for a more   
accurate measurement of the kinetic parameters of antigen 
binding. To arrive at estimates for the parameters that charac-
terize the kinetics of association and dissociation (ka and kd), 
(Fig. 2 B). The suppression of responses to anti-IgG1 and 
anti-kappa were surprising because these antibodies are directed 
to conserved portions of the BCR and not to the antigen- 
binding site. We asked whether suppression was caused   
by the suboptimal signal evoked by 8-mer. If this were the 
case, then presumably any ligand that triggers a comparable 
signal should inhibit subsequent responses to antigen. Thus, 
we lowered the concentration of 17-mer to a concentration 
that elicited a comparable signal with that of the 8-mer at   
0.5 µM; this concentration was 70-times less at 0.007 µM for 
17-mer. Low concentrations (0.007 µM) of 17-mer still blocked 
responses to OVA, anti-IgG, or anti-kappa, almost as effec-
tively as did the 8-mer (Fig. 4 B). Preincubation with AGA 
17-mer did not affect subsequent responses to equimolar 
Figure 3.  Increased valency and N-N orientation favor enhanced B cell stimulation. (A and B) FGD 17-mer (A) or FGD 8-mer (B) peptides were 
linked on an N-N (top structure) or C-C (bottom structure) orientation by click chemistry. Monomers or N-N or C-C dimers for FGD 17-mer at 0.01 
and 0.001 µM (A) or FGD 8-mer at 0.5 µM (B) were added to OB1 B cells loaded with Indo-1 AM, and Ca2+ flux traces were collected. (C) Peptides car-
rying one, two, three, four, and six copies of FGD 8-mer (monomer, dimer, trimer, tetramer, and hexamer, respectively) at 250 nM (top) or 2.5 nM 
(bottom) were added to OB1 B cells that were loaded with Indo-1 AM, and Ca2+ flux traces were collected. Results are representative of two (A and C) 
and three (B) independent experiments.JEM Vol. 211, No. 2 
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When the value of k Lyn on
Lyn [ ] (the rate for Lyn engage-
ment at a single BCR) is greater than the off rate for FGD   
8-mer, all three ligands elicit similar signaling patterns of dou-
bly phosphorylated BCR (Fig. 6 A, left). However, when we 
decrease the value of kon
Lyn  such that k Lyn on
Lyn [ ] is smaller than 
the off rate of 8-mer but larger than the off rates of 17-mer or 
OVA, the results for the three ligands separate (Fig. 6 A, mid-
dle). The ligand that yields the most doubly phosphorylated 
we immobilized OB1 antibody on a sensor chip for surface 
plasmon resonance (SPR) measurements, using intact OVA, 
17-mer, and 8-mer as analytes over a range of concentrations. 
The behavior of these ligands differed markedly in their on 
and off rates, despite having rather similar values for affinity, all 
in the order of 107 M (Fig. 5, A and B): OVA showed a slow 
on and slow off rate, and 8-mer displayed a very fast on and 
very fast off rate. 17-mer shows clearly biphasic binding ki-
netics with an initial rapid on rate, followed by a slower on 
rate and a rapid off rate, followed by slower dissociation. The 
behavior of both OVA and 8-mer as analytes could be fitted 
using a 1:1 mathematical model (one class of homogeneous 
binding sites) to yield the values for ka and kd (Fig. 5 B). How-
ever, the behavior of 17-mer is inconsistent with simple bind-
ing to a homogeneous class of binding sites. The biphasic 
association and dissociation kinetics of 17-mer is consistent 
with a model in which two-state binding related to a confor-
mational change occurs. The values obtained by SPR were 
comparable with the apparent Kd calculated by our competi-
tion ELISA based on the Orosz and Ovádi method (Fig. 5 B; 
Orosz and Ovádi, 2002).
It was puzzling that the 8-mer was unable to fully activate, 
yet blocked responses to the 17-mer and OVA despite com-
parable Kd values. We therefore calculated BCR occupancy 
by these three ligands using a monovalent model for SPR and 
Fab ELISA data (Stone et al., 2011) and a bivalent model for 
intact antibody ELISA data. At 0.5 µM (concentration of   
8-mer used for Ca2+ flux inhibition experiments), 8-mer is es-
timated to occupy 44% of BCR molecules, and for 17-mer 
and OVA the values are 76% and 57%, respectively, with a 
similar trend for Fab ELISA (8-mer = 52%, 17-mer = 68%, and 
OVA = 73%). Using a bivalent model, results were also com-
parable (8-mer occupies 38%, 17-mer 34%, an OVA 52% of 
BCRs). Thus, BCR occupancy does not explain the subopti-
mal stimulation mediated by 8-mer.
To explain the inability of 8-mer to activate the BCR, we 
examined the kinetic behavior of 8-mer, 17-mer, and OVA in 
more detail using computational modeling. 17-mer and OVA 
lead to enhanced Ca2+ flux compared with 8-mer, indicating 
that the off rate of 8-mer is such that the Src family kinase 
Lyn phosphorylated the ITAMs in Ig and Ig suboptimally 
(Fig. 6 A, inset). This would be the case if the time scale for 
Lyn engagement, as set by the concentration of Lyn times the 
on rate for Lyn/BCR engagement, is greater than the dwell 
time of the 8-mer but shorter than that of 17-mer and OVA. 
To further explore this hypothesis, we performed stochastic 
computer simulations of the earliest events in B cell signaling 
using the Gillespie algorithm (Gillespie, 1977). Our simula-
tion included only the earliest downstream events involving 
the Src family kinase Lyn and the phosphatase SHP-1. Our 
read-out of signaling was ITAM phosphorylation. We per-
formed 1,000 simulation runs with the same initial configu-
rations for systems in which the B cell is exposed to OVA, 
17-mer, and 8-mer (represented by the kinetics of their bind-
ing to BCR) and recorded the mean fraction of doubly phos-
phorylated BCR ITAMs at various time points.
Figure 4.  Peptides that bind but do not elicit a response block 
activation by antigen or cross-linking agents. (A) OB1 B cells were 
loaded with Indo-1 AM and incubated for 5 min with 0.5 µM FGD 8-mer 
or media before addition of equimolar FGD 17-mer. (B, top two panels) 
OB1 B cells were incubated with 8-mer at 0.5 µM or 17-mer at 0.007 µM. 
(bottom nine panels) OB1 B cells were preincubated with 8-mer as stated 
in A (middle) or with 17-mer at 0.007 µM (right) for 6 min before addition 
of 0.5 µM OVA (top), anti-IgG at 1 µg/ml (middle), or anti-kappa at 1 µg/ml 
(bottom), and Ca2+ flux traces were collected. Results are representative of 
three independent experiments, except for anti-kappa (two).372 Monovalent engagement of the BCR | Avalos et al.
probability of rebinding of 8-mer upon disengaging from the 
receptor, we took into account two mechanisms for rebind-
ing. One possibility is that an 8-mer that has just dissociated 
from a BCR can rebind immediately before it diffuses over a 
distance commensurate with a characteristic protein molecu-
lar length scale of 100 Å. The second possibility is that, after 
dissociation, the ligand can make one or many diffusive ex-
cursions away from the BCR but returns and ultimately re-
binds, with none of the diffusive excursions exceeding a 
threshold distance. To examine whether this process can occur 
before a 17-mer can bind, the threshold distance is taken to 
be the expected distance to the nearest 17-mer, which we 
compute assuming a uniform concentration of 17-mers (cor-
responding to experimental conditions). Once the 8-mer has 
diffused as far away as the nearest 17-mer, we can treat the 
two as effectively well mixed, with both now being on equal 
footing vis-à-vis binding. We computed the probability of   
8-mer rebinding as a function of both its diffusion coefficient 
and 17-mer concentration in one (1D), two (2D), and three 
dimensions (3D). We carry out calculations as a function of 
dimensionality because the B cell surface is not a perfectly 
smooth sphere, but rather has protrusions and indentations 
that yield closely apposed surfaces that may restrict antigen 
diffusion. Our calculations show that decreasing the dimen-
sionality of the system from 3D to 2D to 1D results in a   
significantly enhanced probability of rebinding (Fig. 6 B).   
Because 8-mer rebinding out-competes the 17-mer, it is 
likely that rebinding of 8-mers interferes with binding of   
17-mers. The effective dimensionality of the B cell surface 
thus is lower than 3D because the distance between opposing 
membrane surfaces can be shorter than the expected distance 
ITAM is the 17-mer because it has the slowest off rate. The 
ligand that elicits the least doubly phosphorylated ITAM is 
the 8-mer because it has the fastest off rate. If a threshold 
level of doubly phosphorylated ITAMs is required to prop-
agate downstream signals, the 17-mer and OVA but not   
the 8-mer will induce signaling. This result is simply a re-
flection of kinetic proofreading, which applies only when 
k Lyn k on
Lyn
off
mer [ ] <
8 . Because we used the same ligand concen-
tration in all of our simulations, 17-mer appears to dominate 
OVA in terms of generating doubly phosphorylated ITAMs. 
However, the initial fast off rate of 17-mer during the bipha-
sic dissociation recorded by SPR suggests that there may be 
two populations of 17-mer bound to BCR, one that is bound 
more strongly than the other. This would result in the effec-
tive concentration of signaling-competent 17-mers to be less 
than that for OVA. When we use a lower effective ligand 
concentration for 17-mer, it has a simulated phosphorylation 
curve comparable with that elicited by OVA (Fig. 6 A, right). 
In light of these calculations, our experimental data suggests 
that indeed  k Lyn k on
Lyn
off
mer [ ] <
8  and that BCRs may be ex-
posed to lower effective concentration of 17-mer.
Because we observed that 8-mer was better at blocking 
responses to OVA when compared with a low concentration 
of 17-mer, we sought to model whether the kinetics of bind-
ing of 8-mer could explain this behavior. Several studies (Bell, 
1978; Aleksic et al., 2010; Govern et al., 2010; Abel et al., 
2012; Tubo et al., 2013) have noted the importance of ligand 
rebinding when the on rate of receptor-ligand binding is 
high. We hypothesized that, upon preincubation with 8-mer, 
its high on rate may lead to many rebinding events before 
OVA or 17-mer could bind to the BCR. To estimate the 
Figure 5.  FGD 17-mer, FGD 8-mer, and OVA share similar Kd but different binding behavior. (A) CM5 chips coated with OB1 antibody were 
subject to Biacore measurements using OVA (left), FGD 17-mer (middle), and FGD 8-mer (right) peptides as analytes, and binding was recorded as relative 
units (RU) at different concentrations of analyte. Data recorded are shown in red, and the model prediction is shown in black. (B) Kinetic parameters cal-
culated by Biacore experiments and competitive ELISAs.JEM Vol. 211, No. 2 
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rebinding events that can inhibit a 17-mer despite its longer 
dwell time. This is a result of both exhaustive effects and direct 
competition at the binding site.
Binding by 8-mer renders B cells nonresponsive  
to cell-bound 17-mer in the presence of CD40 ligation
Because 17-mer and OVA promoted comparable early BCR 
signaling events, we then asked whether later events in B cell 
activation by 17-mer and OVA could be similar also. The   
17-mer induced up-regulation of the co-stimulatory molecule 
CD86, but to a lesser extent than that elicited by OVA and 
anti-IgG1 (Fig. 7 A, left). To test whether 8-mer could block 
CD86 up-regulation, we preincubated OB1 B cells with   
8-mer before addition of equimolar concentrations of 17-mer 
or OVA or a saturating amount of anti-IgG1. Preincubation 
with 8-mer (Fig. 7 A, middle) but not mutant (AGA) 17-mer 
(Fig. 7 A, right) modestly decreased CD86 up-regulation by 
17-mer but not by OVA or anti-IgG1. In vivo, antigen pre-
sentation on cell surface by macrophages and follicular den-
dritic cells appears as a more efficient means of inducing BCR 
responses when compared with soluble antigen (Batista et al., 
2001; Batista and Harwood, 2009). Because OB1 B cells 
showed modest CD86 responses to soluble 17-mer, we ex-
plored whether presentation of 17-mer in a cell-bound form 
would be more efficient and also whether 8-mer could prevent 
to the nearest 17-mer. Thus, rebinding effects can be signifi-
cant, given the fast on rate of the 8-mer and may explain why 
8-mer blocks OVA stimulation better than a low concentra-
tion of 17-mer.
Our calculations, along with the results of these three ex-
periments (8-mer inhibition of 17-mer, 8-mer vs. 17-mer in-
hibition of OVA, and 8-mer vs. 17-mer inhibition of anti-IgG 
and anti-kappa), suggest that a combination of effects are at 
play when preincubation is inhibitory. First, preincubation 
with a ligand that leads to suboptimal signaling results in a re-
fractory effect or exhaustion, thus limiting signaling upon re-
stimulation with another antigen.  This effect is clearly reflected 
in the experimental results using anti-IgG and anti-kappa, 
which show that suboptimal binding alone is enough to in-
hibit subsequent signals (Fig. 4 B), perhaps as the result of 
local depletion of ATP in the vicinity of the BCR. Second, 
competition for ligand binding to the antigen-binding site 
constitutes an additional form of inhibition. 8-mer at 0.5 µM 
shows a better inhibitory effect when compared with a low 
concentration (0.007 µM) of 17-mer upon addition of OVA 
(Fig. 4 B), and this is possibly caused by the 8-mer’s fast re-
binding kinetics as our calculations show (Fig. 6 B). Finally, 
preincubation of 8-mer before addition of 17-mer shows that 
despite the off rate of 8-mer being much higher than that of 
17-mer, the very rapid binding kinetics allow for multiple   
Figure 6.  Computational modeling of OVA, 17-mer, and 8-mer binding and activation. (A) The fraction of doubly phosphorylated ITAM versus 
time for FGD 8-mer, 17-mer, and OVA from stochastic simulations: (left) for the case when k Lyn k on
Lyn
off
mer [ ] >
8  and all peptide concentrations are the same; 
inset shows the level of phosphorylated ITAMs in Ig in response to 17-mer, 8-mer, or OVA; (middle) for the case when k Lyn k on
Lyn
off
mer [ ] <
8  and all peptide 
concentrations are the same; (right) for the case when k Lyn k on
Lyn
off
mer [ ] <
8  and 17-mer is 8% of the OVA and 8-mer concentration. (B) Contour plots show-
ing the probability of 8-mer rebinding as a function of 8-mer diffusion coefficient (y axis) and 17-mer concentration (x axis).374 Monovalent engagement of the BCR | Avalos et al.
modification of type II membrane proteins such as human 
CD40L (Popp et al., 2007). To determine whether the 8-mer 
could block both stimulation by cell-bound 17-mer and the 
contribution of CD40 ligation in a cell-based system, we cre-
ated a Madin-Darby canine kidney (MDCK) cell line that 
stably expresses mouse CD40L modified with the sortase rec-
ognition sequence LPETG, followed by a HA tag. HA-tagged 
CD40L is present in transduced MDCK cells but not in con-
trol cells (Fig. 7 B). We synthesized a 17-mer extended at its 
responses to 17-mer presented on the cell surface. In the pro-
cess, we sought to establish whether co-stimulatory signals 
such as CD40 ligation on B cells could reverse the block-
ade produced by incubation with the 8-mer. We took advan-
tage of a sortase-catalyzed transacylation reaction, which 
allows ligation in flexible linkage of a substrate that contains 
N-terminal (Gly)n, such as a suitably (Gly)n-modified FGD 
17-mer peptide, to a target protein that carries the sequence 
LPXTG at its C terminus. This method has been used for the 
Figure 7.  FGD 8-mer renders B cells unresponsive to cell-bound antigen with engaged CD40L-CD40. (A) OB1 B cells were preincubated with  
5 µM FGD 8-mer or mutant AGA 17-mer for 2 h before addition of 5 µM FGD 17-mer, OVA, or 1 µg/ml anti-IgG1 and incubated for 18 h. Up-regulation of 
CD86 was detected by flow cytometry using anti–CD86-APC. (B) MDCK cells were stably transduced or not with CD40L-LPETG-HA and stained with anti-
CD40L and anti-HA. Cells expressing both CD40L and HA were FACS-sorted and cultured in DMEM in the presence of 250 mg/ml hygromycin B. (C) Un-
transduced or CD40L-LPETG-HA–expressing MDCK cells were incubated with 200 µM FGD 17-mer peptide coupled to GGG and biotin in the absence or 
presence of 100 µM sortase A for 30 min on ice. After that, cells were washed three times with PBS, detached with 8 mM EDTA, and FACS-stained. (left) 
Total CD40L levels. (middle) HA levels. (right) Incorporated biotinylated peptide detected with SA. (D) Untransduced (UT) and CD40L-transduced MDCK 
cells (CD40L-tag) were incubated with peptide alone or in the presence of sortase A as in C, and cells were lysed and analyzed by immunoblotting for 
covalent incorporation of biotinylated peptide to CD40L by SA conjugated to HRP. (E) Representative scheme showing stimulation of B cells by cross-
linked FGD 17-mer peptide on CD40L. (F) Sortase reaction on untransduced or CD40L-carrying MDCK cells was performed as in C. After washing, untrans-
duced or CD40L-LPETG-HA–expressing MDCK cells were co-cultured for 18–20 h with OB1 B cells that were untreated or previously incubated with  
10 µM FGD 8-mer for 2 h. Histograms show CD86 levels on B cells at the indicated conditions. Dashed lines on histograms delimit CD86 negative/low and 
positive/high populations. (G) Graph shows the percentage of B cells expressing high levels of CD86 under different treatments. Results shown are repre-
sentative of three (A, B, and F), two (C and D), and the mean + SD of two (G) independent experiments.JEM Vol. 211, No. 2 
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as more BCR molecules are brought in close proximity, a fea-
ture further enhanced by increasing copy number of the epi-
tope through linear extension.
By changing the length of the peptide, we varied the 
quality of the antigenic stimulus and discerned three qualita-
tively different responses, depending on signal strength and 
binding site of ligand. Both intact OVA and the FGD 17-mer 
elicit a robust response through engagement via the BCR’s 
antigen-binding site, which leads to BCR aggregation. The 
FGD 8-mer triggers a blunted, yet sustained response that 
fails to recruit active kinases to the threshold concentration 
required to achieve an optimal response (Fig. 6 A, inset). 
Cross-linking of the BCR by an anti-Ig reagent, which binds 
sites on the constant regions of IgG, produces a strong re-
sponse by bringing BCRs in close proximity through cross-
linking. Although the qualities of early signals evoked by the 
17-mer and OVA were comparable, the 17-mer caused less 
robust up-regulation of CD86 when compared with OVA,   
a likely result of the allowed overall conformations of these   
ligands and their binding kinetics. Thus, ligands that can 
achieve B cell activation must therefore either be mono-
meric antigens that engage the antigen-binding site and sat-
isfy a defined signaling threshold or ligands that can bring 
together (cross-link) BCR molecules, either through their 
constant or variable regions. We believe this model explains 
the  results  obtained  with  types  of  antigens  that  activate   
B cells but that do not fit the accepted multivalent antigen 
structure (Kim et al., 2006; Minguet et al., 2010) and the   
inability of monomeric Fab anti-IgM to activate B cells 
(Woodruff et al., 1967).
Our findings that the 8-mer could prevent early responses 
to 17-mer or OVA suggested that the 8-mer serves as a weak 
agonist that renders the B cell temporarily nonresponsive. The 
quality of the signal delivered through the BCR determined 
this suppression. Thus, antigens that can bind and signal   
may temporarily incapacitate the BCR to respond to further 
antigen challenge until a B cell fate decision is made. This 
blockade extended not only to bonafide antigens, but also 
to treatment with anti-IgG and anti-kappa as cross-linking 
agents, suggesting that the reduction in the response may be 
caused by a conformational change in BCR induced by   
8-mer or by a feedback inhibitory mechanism perhaps under 
the agency of phosphatases that act downstream of the BCR. 
The low-grade yet persistent Ca2+ flux elicited by 8-mer, still 
observed after 1 h of stimulation, is consistent with observa-
tions of increased basal intracellular Ca2+ in anergic B cells 
from the HEL and Ars/A1 models (Cambier et al., 2007). In 
the Ars model, blockade required constant receptor occu-
pancy (Gauld et al., 2005). In our hands, the inhibitory effect 
elicited by the 8-mer also required its continuous presence;   
B cells preincubated with 8-mer regained responsiveness to 
the 17-mer after washing cells in a timeframe consistent with 
dissociation of the 8-mer (unpublished data). Moreover, the 
8-mer could still block responses to B cells receiving antigen 
presented in a cell-bound high-avidity configuration (signal 1), 
in conjunction with provision of the CD40-CD40L signal 
N terminus with GGG and performed a sortase reaction using 
the MDCK CD40L-LPETG line. A successful reaction cova-
lently ligates the GGG-extended 17-mer to surface-exposed 
CD40L (CD40L-peptide) with concomitant loss of the HA 
tag located downstream of the LPETG sequence. Upon in-
cubation with sortase and peptide substrate, levels of surface 
CD40L were unchanged, whereas the percentage of HA- 
labeled cells decreased (Fig. 7 C, left and middle), indicative of 
a successful transacylation reaction. Peptide linkage to CD40L 
was monitored by using a biotinylated version of the GGG-17-
mer, detected upon completion of the reaction by streptavi-
din (SA)-HRP (Fig. 7 C, right) and by Western blot (Fig. 7 D). 
Upon co-culture of OB1 B cells with such modified MDCK 
cells, which carry both CD40L and the 17-mer, ligation of 
CD40 on B cells and 17-mer peptide engagement of BCR 
should up-regulate CD86 on B cells (Fig. 7 E). Untransduced 
cells failed to up-regulate CD86 in the absence or presence   
of 17-mer alone or with sortase (Fig. 7 F, left). As expected, 
MDCK cells transduced with CD40L were able to up-regulate 
CD86 on B cells in the absence of peptide, indicating that 
CD40L was engaging CD40 on B cells (Fig. 7, F [right, blue 
histogram] and G). Upon covalent conjugation of peptide to 
CD40L on MDCK cells, OB1 B cells expressed higher levels 
of CD86 than OB1 B cells co-cultured with MDCK cells in 
the absence of covalently conjugated FGD 17-mer (Fig. 7,   
F [right, black and red histograms] and G). In this setting, pre-
incubation of OB1 B cells with 8-mer for 2 h precluded   
responses to CD40L-linked 17-mer (Fig. 7, F [right, gray his-
togram] and G). Thus, preincubation with 8-mer blocks re-
sponses to cell-bound FGD 17-mer, even in the presence of 
the CD40L co-stimulatory signal.
DISCUSSION
OVA has a long history as a model antigen to study adaptive 
immune responses, especially for CD4 and CD8 T cells, but 
comparatively little is known about OVA-specific B cells.   
The OVA-specific OB1 mouse is currently the only animal 
model with monoclonal primary IgG1 B cells that recognize a 
sequence-defined epitope on an intact protein, OVA. Equally 
important, this epitope can be displayed functionally as a 
short synthetic peptide. Using peptides of defined composi-
tion as ligands, we explored valency requirements for BCR 
engagement. Our data support the ability of monovalent an-
tigen to elicit a response in two ways. First, we showed that 
17-mer was stimulatory in the absence of serum. Second, sub-
optimal stimulation by the 8-mer was vastly improved by di-
merization, suggesting indeed that the 8-mer was present as a 
monomer in solution. Dimerization and multimerization of 
antigen increase the population of B cells able to flux Ca2+, 
with N-N dimers somewhat more favorable than C-C di-
mers. By estimating the dimensions of Fab as 65 × 35 Å 
(Green, 1969), the volume of the 8-mer at 1,000 Å3 and the 
linker between dimers at 30 Å when fully extended, we can 
now model how peptide orientation may favor more or less 
extensive cross-linking of the BCR. Thus, epitope dimeriza-
tion with an N-N orientation contributes to better activation, 376 Monovalent engagement of the BCR | Avalos et al.
the  resin  was  swollen  in  NMP,  deprotected  with  20%  piperidine/NMP, 
washed, coupled with heptynoic acid (3 equiv) using HBTU (3 equiv) and 
DiPEA (6 equiv) in NMP, and finally washed again. C-terminally modified 
peptides were obtained by removing the Mtt group of the C-terminal lysine 
residue with 1% TFA, 1% TIS in CH2Cl2, washing the resin, coupling of hep-
tynoic acid, washing, deprotecting with 20% piperidine/NMP, and washing 
again. After the final washing step, the modified peptides were cleaved off the 
resin with 94% TFA, 2% H2O, 2% TIS, and 2% ethanedithiol, precipitated in 
ice-cold diethyl ether, collected by centrifugation, dried, and purified using 
reverse-phase HPLC. Homodimeric peptides were prepared by incubating 
the monomers (2.0–2.15 equiv) with a mixture of diazido linker (1 equiv), 
CuSO4 (0.1 equiv), and sodium ascorbate (0.15 equiv) in tBuOH/H2O. The 
resulting azido-linker-peptide products were purified by size exclusion col-
umn chromatography before being conjugated to the second peptide. All   
dimeric peptides were purified to homogeneity by reverse-phase HPLC fol-
lowed by size-exclusion chromatography.
Labeling of peptides with Alexa Fluor 647. FGD 17-mer and AGA   
17-mer peptides carrying a cysteine at the C terminus were dissolved in 200 µl 
PBS/DMSO (1/1 vol/vol) and added to 1 mg Alexa Fluor 647–maleimide. 
The reaction was incubated at room temperature for 16 h before being 
quenched with 0.1% aqueous TFA. The labeled peptides were purified by re-
verse-phase HPLC, and the product fractions were lyophilized to a powder.
Confocal microscopy. OB1 MHC II GFP or FluB1 MHC II GFP B cells 
were purified and attached to poly-l-lysine–coated chamber slides in phenol 
red–free RPMI medium supplemented with 10% heat-inactivated FBS. The 
temperature was at 22°C. Alexa Fluor 647 versions of FGD 17-mer and AGA 
17-mer were added to B cells at 1 µM for 10 min and washed three times 
with RPMI medium and imaged immediately in an Ultraview spinning disk 
confocal microscope (PerkinElmer) equipped with an ORCA-ER CCD 
camera (Hamamatsu Photonics). Image acquisition and analysis were per-
formed using the  Volocity software (PerkinElmer), and the intensity of display 
signal was normalized between all images.
STORM imaging. OB1 B cells in serum-free RPMI were attached to 
poly-l-lysine–coated chamber slides, incubated with 100 µM dynasore for   
1 h, and placed on ice for 2 min, stimuli were added (17-mer at 2.5 µM and 
anti-IgG at 5 µg/ml) for 10 min on ice, and then chamber slides were moved 
to 37°C for 15 min. Samples were fixed in 4% paraformaldehyde for 10 min 
and stained with donkey anti–mouse IgG (Jackson ImmunoResearch Labo-
ratories, Inc.) conjugated with Alexa Fluor 405 and Alexa Fluor 647 for 3D 
STORM imaging in MEA imaging buffer (He et al., 2013). STORM ex-
periments were performed as previously described on a homemade STORM 
microscope constructed around an Olympus IX71 body (Jones et al., 2011) 
at room temperature. Near total internal reflection angle was used during 
imaging acquisition to reduce background fluorescence from the rest of the 
cell. The depth of illumination was several hundred nanometers axially, so 
that only a section of the cell is imaged. Two lasers (657 nm, RCL-300-656 
[CrystaLaser]; and 405 nm, CUBE 405-50C [Coherent]) were combined and 
focused to the back focal plane of a high numerical aperture (NA) oil- 
immersion objective (100× UPlanSapo, NA1.4; Olympus), which is imaged 
onto a back-illuminated electron-multiplying charge-coupled device (EMCCD) 
camera (iXON DU-897; Andor). A dichroic long-pass mirror (T660LPXR; 
Chroma) was used to reflect the excitation beams, and the fluorescence emis-
sion was further filtered with a band-pass filter (ET705/72m; Chroma). A 
cylindrical lens (focal length = 10 m) was inserted into the imaging path to 
create astigmatism for 3D imaging (Huang et al., 2008). STORM imaging 
was performed at 60 Hz and imaged onto 256 × 256 pixels in the EMCCD 
camera. The images were drift-corrected and generated using similar meth-
ods as previously described (Huang et al., 2008). The spatial resolution mea-
sured was 20–30 nm laterally and 50–60 nm axially for Alexa Fluor 647. 
We randomly selected different regions of the sample to image for each treat-
ment, which usually contained several cells per image, and there was no bias 
on the choice of imaging focal plane. After imaging acquisition, for cluster 
(signal 2). Thus, the 8-mer may induce a state of anergy that 
can still persist in the presence of co-stimulation.
An important aspect of our model is the presence of IgG1 
BCR on the surface. The OB1 IgG1 displays moderate affin-
ity for OVA and peptides (107) even having undergone   
somatic hypermutation (Dougan et al., 2012). It has been   
reported that class-switched BCRs such as IgG1 respond bet-
ter to antigen because of their higher affinity for antigen, the 
presence of a cytoplasmic tail absent from IgM and IgD (Kaisho 
et al., 1997) that enhances antibody production and clonal 
expansion (Martin and Goodnow, 2002), and the ability to 
better cluster and activate in response to membrane-bound 
antigen (Liu et al., 2010). The identity of the constant region 
of Ig may also influence the variable regions; antibodies of 
different isotypes but with identical variable regions can ex-
hibit differences in specificity, affinity, and effector function 
(Casadevall and Janda, 2012; Tudor et al., 2012). Thus, class-
switched BCRs may exhibit antigen requirements that differ 
from their IgM counterparts to ensure prompt responses to 
antigen reencounter in the course of a memory response. 
Further studies comparing antigen-specific BCRs with dif-
ferent isotypes should help clarify whether this is indeed the 
case, and somatic cell nuclear transfer may prove to be an effi-
cient means to generate such models.
MATERIALS AND METHODS
Mice and reagents. Transnuclear OB1 RAG1/ (mixed C57BL/6 and 
129 background), OB1 RAG-proficient (C57BL/6 background), and FluB1 
mice have been described previously (Dougan et al., 2012, 2013). OB1/
MHC II GFP and FluB1/MHC II GFP were generated by crossing animals 
in the C57BL/6 background. All animals were maintained under specific 
pathogen–free conditions, and experiments were performed with approval of 
the Committee for Animal Care and the Association for the Assessment and 
Accreditation of Laboratory Animal Care. Monomeric peptides bearing bio-
tin at the N-terminal end (N-terminal biotin; FGD 12-mer, 8-mer, 4-mer, 
8-mer dimer, trimer, tetramer, and hexamer) or at the epsilon amine of lysine 
(C-terminal biotin; FGD 17-mer, AGA 17-mer, 17-mer subs, 17-mer hy-
droph, 17-mer AGD, and 17-mer FGA), (Gly)3 at the N terminus, or FGD   
8-mer, 17-mer, and AGA 17-mer bearing cysteine at the C terminus for 
conjugation of maleimide–Alexa Fluor 647 were synthetized at the Biopoly-
mers Laboratory at MIT. OVA was purchased from Sigma-Aldrich. Antibod-
ies and SA used for flow cytometry were obtained from BD. Indo-1 AM was 
purchased from Invitrogen. Anti-IgG1 (unlabeled and conjugated to HRP) 
was obtained from SouthernBiotech. Anti–Fab-HRP was obtained from Sigma-
Aldrich. O-benzotriazole-N,N,N,N-tetramethyl-uronium hexafluorophos-
phate (HBTU) was purchased from EMD Millipore. DriSolv anhydrous CH2Cl2, 
DriSolv anhydrous MeOH, and DriSolv anhydrous DMF were purchased 
from EMD Millipore. Redistilled, anhydrous N,N-diisopropylethylamine 
(DiPEA), TFA,  triisopropylsilane  (TIS),  N-methylpyrrolidone  (NMP),   
heptynoic acid, and ethanedithiol were obtained from Sigma-Aldrich. 1,5-diaz-
ido-3-oxopentane was purchased from Santa Cruz Biotechnology, Inc. 1,11-
diazido-3,6,9-trioxaundecane was synthesized as described in the literature 
(Lüning et al., 1990). Btk inhibitor was synthetized in house and was previ-
ously reported (Strijbis et al., 2013).
B cell purification. Untouched B cells from OB1 RAG1/ mice were puri-
fied by negative selection using CD43 Dynabeads (Life Technologies) ac-
cording to the manufacturer’s recommendations. Purity was always >90–95%.
Synthesis of dimeric peptides. The protected peptides were synthesized 
on an automated solid phase peptide synthesizer and subsequently the C or 
N terminus was modified with heptynoic acid. For N-terminal modification, JEM Vol. 211, No. 2 
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and antigens were then injected at various concentrations (9.75–2,500 nM for 
FGD 8-mer and FDG 17-mer, 7.8–1,000 nM for OVA) at 100 µl/min for   
110 s and allowed to dissociate for 300–600 s. To regenerate the chip surface, 
10 mM glycine, pH 2.2, was injected for 60 s at 30 µl/min. The association, disso-
ciation, and equilibrium dissociation constants were determined from dou-
ble referenced sensorgram with Biacore T100 Evaluation Software version 
1.1.1, using either 1:1 binding or conformational change model.
Calculation of fraction of occupied BCR. The BCR occupancy of 
FGD 8-mer, FGD 17-mer, and OVA was calculated using a monovalent 
model for SPR and Fab ELISA data (Stone et al., 2011); a bivalent model was 
used for intact antibody ELISA data. The method is detailed in the Supple-
mental materials and methods.
Stochastic simulations of earliest events of B cell signaling. Stochastic 
simulations were performed inside a simulation box with an area of 4 µm2 
and a total volume of V = 0.08 µm3. The volume was chosen in such a way 
that diffusion within the box is much faster than the time scales of the chemi-
cal reactions. Under these conditions, the simulation box is well mixed. The 
ligand concentration was held constant throughout the simulation. The frac-
tion of doubly phosphorylated ITAMs was averaged over 1,000 simulation 
runs. Parameters used in calculations are described in the Supplemental ma-
terials and methods. Rate constants used in the stochastic simulations are 
shown in Table S1. Concentrations used in the stochastic simulations are 
shown in Table S2.
Calculation of the probability of rebinding of 8-mers. To compute the 
probability for 8-mer rebinding in 1D, 2D, and 3D cases, we consider both 
immediate rebindings and also rebindings that occur after the FGD 8-mer 
has made one or many diffusive excursions >100 Å away (a molecular dis-
tance), but closer than the expected distance to the nearest FGD 17-mer. The 
procedure for calculating the FGD 8-mer rebinding probability is detailed in 
the Supplemental materials and methods.
Stable transduction of MDCK cells with CD40L-LPETG construct. 
Mouse CD40L bearing an LPETG-HA tag was cloned into pLHCX vector 
and used to make retrovirus by transfecting HEK 293T cells with pLHCX-
CD40L, VSVG, and Gag-Pol constructs. Retrovirus was used to infect 
MDCK cells as described previously (Popp et al., 2012), and cells were se-
lected and maintained in 250 µg/ml hygromycin B.
Immunoblotting. OB1 B cells were equilibrated at 37°C before addition 
of stimuli. Lysates were analyzed by SDS-PAGE and immunoblotting using 
anti–P-ERK or anti–P-CD79A (phosphor-Ig) and anti–total ERK or anti–
-actin for equal loading (CST). For detection of peptide linkage to CD40L 
on MDCK cells by sortase, lysates of MDCK cells that were treated as de-
scribed above were lysed in RIPA buffer and analyzed by immunoblotting 
using SA-HRP.
Peptide binding and CD86 up-regulation in response to soluble 
antigen. For binding, OB1 B cells were incubated with biotinylated pep-
tides on ice and stained with SA-APC. For CD86 up-regulation, untouched 
OB1 B cells were incubated with peptides, OVA, or anti-IgG1 for 18–20 h 
and stained with anti–CD86-APC. To detect inhibition by FGD 8-mer,   
B cells were preincubated with FGD 8-mer for 2 h before stimulation with 
soluble peptide, OVA, or anti-IgG1. Flow cytometry data were plotted using 
FlowJo software.
Sortase-catalyzed covalent linkage of peptide to CD40L on MDCK 
cells and incubation with B cells. Untransduced or CD40L-transduced 
MDCK cells were plated at a density of 50,000 in 24-well plates and allowed 
to attach overnight. Cells were washed twice with PBS and 200 µM biotinyl-
ated GGG FGD 17-mer peptide alone or peptide + sortase A (Chen et al., 
2011) at 100 µM was added in DME/10% FBS and incubated on ice for   
30 min. Cells were washed three times in PBS, and untouched OB1 B cells 
analysis, we used a density-based clustering of application with noise (DB-
SCAN) cluster algorithm with an  value of 53 and n value of 25, as previ-
ously described for STORM image cluster analysis (Kim et al., 2013). Single 
antibody signal scattered on the chamber slide was used to calculate the mean 
number of localizations for an antibody. Since binding of antibody to its tar-
get does not alter the switching property of STORM dye pairs, the number 
of localizations coming from a single antibody bound to monomeric BCR 
should be the same as that of antibody bound to the chamber slide. The pa-
rameters were chosen to make sure the algorithm could distinguish single 
antibody and background signal. Using the mean number of localizations 
from a single antibody as a reference for all experimental conditions, we then 
quantified the clusters having more than three antibodies.
We systematically quantified the number of localizations for all the iden-
tified clusters, the size area of each cluster, and the molecule density (number 
of localization within the cluster/size area). The percentage of clusters that 
have more than three single antibody binding (presumably more than three 
BCRs), the mean size area, and the number of localizations per cluster were 
calculated. At least 60 cells were analyzed for each treatment condition (un-
stimulated 67, 17-mer 102, and anti-IgG 118 cells). Unpaired Student’s t test 
was performed using the total numbers of localizations/clusters and size of 
clusters contained in the cells (unstimulated 498, 17-mer 1,159, and anti-IgG 
899), and the mean percentage of clusters above three BCRs in five (unstim-
ulated) and six (17-mer and anti-IgG) independent fields was calculated.
Generation of hybridomas and antibody purification. OB1 B cells 
were cultured for 5 d in the presence of 20 ng/ml TGF- and 40 µg/ml LPS. 
Cells were then fused with NSObcl2 myeloma partner (B. Diamond, The 
Feinstein Institute for Medical Research, Manhasset, NY), and positive colo-
nies were recloned by limiting dilution and screened by ELISA using plates 
coated with OVA and developed using anti–IgG1-HRP. OB1 IgG1 antibody 
was purified from hybridoma supernatants using Protein G, eluted using 0.1 M 
glycine, pH 2.7, on 1:20 volume of Tris-HCL, pH 8.5, to neutralize the pH and 
then dialyzed against PBS. Fab fragments were generated by digestion with 
immobilized papain activated with Cysteine HCl (Thermo Fisher Scientific) 
overnight at 37°C with shaking. Resulting Fab and Fc fragments were dia-
lyzed against PBS and separated by size-exclusion using Sephadex S75.
Measurement of Ca2+ flux. OB1 B cells were resuspended in 10% heat-
inactivated  FCS  or  serum-free  phenol  red–free  RPMI  and  labeled  with 
Indo-1 AM for 30 min at 37°C. Cells were washed and left at room tempera-
ture to enable desterification (and thus impermeabilization) of the Indo dye. 
Cells were then equilibrated at 37°C, and signal at 485 nm (HI) and 410 nm 
(LO) was collected for 1 min to record baseline Ca2+ levels as the ratio of 
Indo LO/HI. Cells were then stimulated and Ca2+ levels recorded for addi-
tional 5 min. For inhibition experiments, B cells were preincubated at 37°C 
for 30 min (Btk inhibitor) or 5–8 min (8-mer) before data collection. Data 
were collected in a FACS LSR instrument (BD) and analyzed using FlowJo 
software (Tree Star).
ELISA. 96-well plates were coated with 0.1 µM OVA in PBS overnight at 
4°C, blocked in 10% FBS/PBS, and 25 µl OB1 antibody at 50 ng/ml or Fab 
at 500 ng/ml was added in the presence of 25 µl of increasing concentrations 
of peptides diluted in 10% FBS/PBS as described in the Results and incubated 
for 2 h at room temperature. Plates were washed three times with PBS-T and 
then incubated with anti–IgG1-HRP (SouthernBiotech) or anti–Fab-HRP 
(Sigma-Aldrich) at a 1:1,000 dilution in 10% FBS/PBS for 1 h and developed 
with an OptEIA TMB substrate reagent kit (BD), and the reaction was stopped 
with 1M sulfuric acid and plate read at 450-nm absorbance.
Biacore. The binding kinetics between the OB1 mAb and antigens (FGD   
8-mer, FGD 17-mer, and OVA) was determined using SPR on a Biacore T100 
with Series S CM5 sensor chip and standard running buffer 1× HSB-EP+ (GE 
Healthcare). The OB1 antibody was immobilized onto the sensor chip using di-
rect amine coupling or via anti–mouse Ig capture kit (GE Healthcare) according 
to the manufacturer’s specifications. The mAb was captured as 1,500–2,500 RU, 378 Monovalent engagement of the BCR | Avalos et al.
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